Skip to main content
. 2018 Nov 23;12:119. doi: 10.1186/s13065-018-0482-6

Fig. 2.

Fig. 2

FT-IR characterization of a m-HAP, b neat 6-gingerol, c 6-Gin-m-HAP, d neat doxorubicin, e Dox-m-HAP, f 6-Gin + Dox-m-HAP